Summarized by Masters of Longevity from PR Newswire.
Population genomic screening outcomes and related clinicogenomic research presented at a major genetics meeting, previewing talks and posters across multiple disease areas.
Key Takeaways
- Population genomic screening identified previously undiagnosed genetic risk and improved preventive care across diverse health systems over three years.
- A linked resource of over 620,000 paired EHR, claims, and genomics records enabled measurement of real-world clinical outcomes at scale.
- Genotype-informed findings influenced treatment responses and disease trajectories, including pharmacogenomics and APOE-associated dementia risk.
